NEWS

LATEST NEWS

2020

  • November - MLM Biologics receives approval for ISO-13485 certification at its new facility
  • July - MLM Biologics introduces new bio-ConneKt® size for treating large wounds
  • January - Chandra Nataraj, Ph.D. founder of MLM Biologics, presents to the Arthroscopy & Regenerative Medicine Cadaver Lab in Jonesboro, GA
  • January - bio-ConneKt® Wound Matrix establishes new monthly usage level

2019

2018

  • November - Surgeon training in the Middle East. Surgeons from 5 countries in attendance
  • October - MLM Biologics introduces two new preferred bio-ConneKt® sizes for out-patient use
  • September - bio-ConneKt® is placed on the national SAC-VA IDIQ biologics contract (#36C10G18DO127)
  • July - MLM Biologics partners with Pediatric Surgery Centers in the Tampa area to assist in managing patients undergoing difficult to heal pilonidal cyst surgery

2017

2016

  • January - received first Medicare Administrative Contractor territory approvals covering 12 states

2015

  • December - second major investment from private entity into MLM Biologics
  • November - CMS establishes Q4161 as a stand-alone HCPCS code for bio-ConneKt® Wound Matrix to become effective January 1, 2016
  • October - Major investment from private entity into MLM Biologics
  • March - Chandra Nataraj founder of MLM Biologics, presents at the Gainesville Area Innovation Network (GAIN) meeting
  • February - Received ISO 13485 Certification for our facility in Alachua, FL

2014

  • December - Submitted to CMS for product specific HCPCS code
  • October - First bio-ConneKt® Wound Matrix product applied
  • July - Received 510(k) clearance from the FDA for bio-ConneKt® Wound Matrix

2013

  • January - The USPTO issued a Notice of Allowance for the trademark application of bio-ConneKt® Wound Matrix

2012

  • October - MLM Biologics is incorporated as a Delaware corporation